tirzepatide high blood pressure for Weight Loss Beyond weight loss, tirzepatide may

A Research Overview Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor

Important safety considerations include: Caution in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (patients should be counselled about thyroid symptoms) Previous serious hypersensitivity to tirzepatide Pregnancy or breastfeeding (effective contraception required in women of childbearing potential) Caution in patients with gastrointestinal disease, particularly severe gastroparesis History of pancreatitis (requires careful assessment) Women using oral contraceptives should use additional barrier contraception for 4 weeks after starting tirzepatide and after each dose increase, or consider non-oral contraceptive methods In the UK, tirzepatide for weight management may be available through private prescription , while NHS availability would depend on NICE guidance and local commissioning decisions

Most people find that their food tolerances have expanded significantly from where they were during initial treatment

Get Started Now Your Weight Loss Journey Starts Here

Promising data doesnt always equal better outcomes IRL